Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 43063-468

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 43063-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 01

Chemical structure of Lisinopril dihydrate shown as a molecular diagram with atomic and bond representations, including two water molecules associated (2H2O).*

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 02

Chemical structure of Hydrochlorothiazide, one of the active ingredients in Lisinopril and Hydrochlorothiazide tablets by PD-Rx Pharmaceuticals, Inc.*

FDA Label Image

Image (43063468)

Prescription label for Lisinopril and Hydrochlorothiazide 20 mg/25 mg oral tablets. The label indicates a quantity of 90 tablets, manufactured or labeled by PD-Rx Pharmaceuticals, Inc. from Oklahoma City, OK. Includes FDA-required warnings and dosage instructions placeholders, along with the product NDC 43063-468-90 and expiration date 08/2023.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.